Bahi A, Tolle V, Fehrentz JA, Brunel L, Martinez J, Tomasetto CL, et al
Forty-five of the 49 sites prescribed a GLP-1 medication, including some that issued a prescription within five minutes
That means proactive screening, connected data, and AI-driven patient finding to identify risk years earlier when intervention can still make the difference
Intervention Seventy eligible participants were randomly assigned (1:1) to either semaglutide 2.4 mg weekly (Novo Nordisk) ( n = 35) or placebo (saline solution) ( n = 35), using self-administered once-weekly subcutaneous injections with identical-appearing pens
The synergistic effects can overwhelm the body, leading to severe nausea, cardiovascular strain, and other adverse reactions
Do not recap used needles